antimicrobial wound dressings
FEATURED
Less than 1 min.Read

Revolutionary Breakthrough: New Antimicrobial Wound Dressings Unveiled at EWMA 2024

Contributing to this year’s theme at the annual EWMA Conference, ‘Collaborative and Sustainable Wound Care’, experts from Avery Dennison Medical and Polaroid Therapeutics will lead an insightful discussion. Discover how partnership can bring a unique approach to antimicrobial wound dressings.

antimicrobial wound dressings

Polaroid Therapeutics

The 20-minute session explores the synergy of Polaroid Therapeutics’ cutting-edge technology in the development of antimicrobial compounds and Avery Dennison Medical’s renowned expertise in materials science and wound care solutions, resulting in the creation of an innovative antimicrobial platform that elevates patient care and provides solutions to modern global health challenges.

Details of the session:

Title: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

Speakers: Mr Ran Frenkel, CEO, Polaroid Therapeutics; and Dr. Emmett McArdle, Advanced Research and Development Manager at Avery Dennison Medical.

Date and time: Wednesday, May 1st, 2024, from 15:15 to 15:35.

Room: EWMA ARENA (E-Poster Area).

Conference venue: ExCeL London.

All participants to the EWMA Conference can attend this session, no prior registration is needed.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

0
Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

0
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

0
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

0
Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

0
Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York, No. Carolina
United States
Phone Number: 1.561.316.3330